Isotretinoina Difa (Isotretinoin)

Isotretinoin binds to nuclear retinoic acid receptors, altering gene expression to shrink sebaceous glands, lower sebum production, normalize follicular keratinisation, and exert anti‑inflammatory effects, thereby targeting the core mechanisms of severe acne.

The dosage of isotretinoin is individualized by the prescribing clinician based on factors such as body weight, severity of acne, and laboratory parameters. Patients should follow the prescriber’s specific instructions and not alter the dose on their own.

Isotretinoin is classified as pregnancy category X because it can cause severe birth defects. It is contraindicated in pregnancy and women must use effective contraception. Breastfeeding is also not recommended while taking the medication.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Unlike topical agents or oral antibiotics, isotretinoin targets the underlying pathophysiology of severe acne by reducing sebum output and normalising follicular keratinisation. It is generally reserved for cases that are refractory to conventional therapies because of its potency and risk profile.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Isotretinoina Difa is taken orally, usually with a meal to improve absorption. The exact regimen, including frequency and duration, is determined by the treating physician based on individual patient needs.

The most serious risks include teratogenicity (birth defects), severe depression or mood changes, hepatotoxicity, pancreatitis, and significant elevations in triglycerides. Patients should be monitored regularly for these adverse events throughout therapy.

Isotretinoina Difa should not be used by pregnant women, individuals planning pregnancy, or those who cannot commit to effective contraception. It is also contraindicated in patients with known hypersensitivity to isotretinoin or other retinoids.